Search results
AstraZeneca's breast cancer drug combination fails in late-stage trial
Reuters via Yahoo News· 24 hours agoTriple-negative breast cancer remains one of the most challenging forms of disease to treat due to...
AstraZeneca's Combination Cancer Drug For Advanced Breast Cancer Study Flunks Late-Stage Trial -...
Benzinga· 18 hours agoThe study did not meet the dual primary endpoints of improvement in overall survival (OS) versus...
UPMC moving forward with clinical trials for early stage breast cancer vaccine
Pittsburgh Tribune-Review· 15 hours agoThrough an upcoming clinical trial, approximately 50 women will receive a new vaccine for early-stage breast cancer developed by UPMC ...
Reveal Genomics launches HER2+ breast cancer diagnostics trial
Medical Device Network via Yahoo Finance· 15 hours agoSpanish biotech start-up, Reveal Genomics, has announced the launch of a trial evaluating the...
ShortFest 2024: Filmmakers share inspirations behind films at Opening Night
The Desert Sun via Yahoo News· 1 hour agoDirector Kailee McGee does just that with her meta film, "Can." As she grapples with her late-stage ...
Recognizing signs of breast cancer in older women
Medical News Today· 6 days agoMost breast cancers are found in females aged 45 years or older, with the average age of diagnosis being around 62 years. Early signs of breast ...
AstraZeneca's Advanced Breast Cancer Drug Fails to Meet Primary Goals
Morningstar· 1 day agoAstraZeneca said a late-stage study showed that its therapy for advanced or metastatic triple-negative breast cancer didn't meet its ...
UK cancer care lagging 20 years behind Europe
The Telegraph via Yahoo News· 8 hours agoAn NHS spokesman said: “The NHS is seeing and treating record numbers of people for cancer, with more people diagnosed at an earlier stage than ever...
US FDA puts partial clinical hold on BioNTech’s early-stage study of cancer drug
WHTC 1450 Holland· 2 days ago(Reuters) - Germany's BioNTech SE said in a regulatory filing on Monday the U.S. Food and Drug...
AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study
Zacks via Yahoo Finance· 16 hours agoAstraZeneca's (AZN) phase III CAPItello-290 study evaluating Truqap plus chemotherapy in patients...